Powering Precision Proteomics
Alamar Biosciences, Inc. is a life science tools company founded in 2018 and headquartered in Fremont, California. The company develops and commercializes the NULISA platform — a next-generation proteomics technology enabling ultra-high sensitivity protein quantification at scale. Alamar's solutions are used in biomarker discovery, early disease detection (including cancer and neurodegenerative diseases), and pharmaceutical research. The company has raised over $170M and serves academic research centers and biopharma customers globally.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2026
Feb 2024
Sep 2021
May 2020
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
